Author: | Stefan Breitenstein, Jacques Belghiti, Ravi S. Chari, Josep M. Llovet, Chung-Mau Lo, Michael A. Morse, Tadatoshi Takayama, Jean-Nicolas Vauthey | ISBN: | 9781444356397 |
Publisher: | Wiley | Publication: | September 23, 2011 |
Imprint: | Wiley-Blackwell | Language: | English |
Author: | Stefan Breitenstein, Jacques Belghiti, Ravi S. Chari, Josep M. Llovet, Chung-Mau Lo, Michael A. Morse, Tadatoshi Takayama, Jean-Nicolas Vauthey |
ISBN: | 9781444356397 |
Publisher: | Wiley |
Publication: | September 23, 2011 |
Imprint: | Wiley-Blackwell |
Language: | English |
This comprehensive and critical review of current and established treatment modalities for malignant liver tumors is designed to help you sort through the proliferation of competitive approaches and choose the best treatment options for your patient. Dr. Clavien and his contributors consider all the options – radiological, surgical, pharmaceutical, and emerging/novel therapies – and help you find the best single or combined therapy.
Building on the success of the previous edition, this extremely thorough revision:
In 44 chapters organized into six major sections, the book covers the full range of liver tumors. The perfect blend of evidence and experience, Malignant Liver Tumors: Current and Emerging Therapies, 3rd Edition, illuminates the path to better patient care.
This comprehensive and critical review of current and established treatment modalities for malignant liver tumors is designed to help you sort through the proliferation of competitive approaches and choose the best treatment options for your patient. Dr. Clavien and his contributors consider all the options – radiological, surgical, pharmaceutical, and emerging/novel therapies – and help you find the best single or combined therapy.
Building on the success of the previous edition, this extremely thorough revision:
In 44 chapters organized into six major sections, the book covers the full range of liver tumors. The perfect blend of evidence and experience, Malignant Liver Tumors: Current and Emerging Therapies, 3rd Edition, illuminates the path to better patient care.